[1]
|
Lepper, P.M., Held, T.K., Schneider, E.M., Bolke, E., Gerlach, H. and Trautmann, M. (2002) Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Medicine, 28(7), 824-833.
|
[2]
|
Parratt, J.R. (1998) Nitric oxide in sepsis and endotoxaemia. Journal of Antimicrobial Chemotherapy, 41(1), 31-39.
|
[3]
|
Hegemann, F. and Lessmann, H. (1958) Nature of the pyrogen-neutralizing factor in human blood. V. occurrence of the endotoxinneutralizing serum factor in various animal species. Zeitschrift Für Immunitatsforschung Und Experimentelle Therapie, 115(5), 391-401.
|
[4]
|
Stauch, J.E. and Johnson, A.G. (1959) The alteration of bacterial endotoxins by human and rabbit serum. Journal of Immunology, 82, 252-263.
|
[5]
|
Abdelnoor, A.M., Harvie N.R. and Johnson A.G. (1982) Neutralization of bacteria-and endotoxin-induced hypotension by lipoprotein-free human serum. Infection and Immunity, 38(1), 157-161.
|
[6]
|
Cherkin, A. (1975) Destruction of bacterial endotoxin pyrogenicity by hydrogen peroxide. Immunochemistry, 12(6-7), 625-627.
|
[7]
|
Noll, H. and Braude, A.I. (1961) Preparation and biological properties of a chemically modified escherichia coli endotoxin of high immunogenic potency and low toxicity. Journal of Clinical Investigation, 40(11), 1935-1951.
|
[8]
|
Nowotny, A. (1963) Endotoxoid preparations. Nature, 197(4868), 721-722.
|
[9]
|
Ribi, E., Anacker, R.L., Brown, R., Haskins, W.T., Malmgren, B., Milner, K.C., et al. (1966) Reaction of endotoxin and surfactants. I. physical and biological properties of endotoxin treated with sodium deoxycholate. Journal of Bacteriology, 92(5), 1493-1509.
|
[10]
|
Tarmina, D.F., Milner, K.C., Ribi, E. and Rudbach, J.A. (1968) Reaction of endotoxin and surfactants. II. Immunologic properties of endotoxins treated with sodium deoxycholate. Journal of Immunology, 100(2), 444-450.
|
[11]
|
Keene, W.R., Landy, M. and Shear, M.J. (1961) Inactiva- tion of endotoxin by a humoral component. VII. enzymatic degradation of endotoxin by blood plasma. Journal of Clinical Investigation, 40, 302-310.
|
[12]
|
Yoshioka, M. and Johnson, A.G. (1962) Characteristics of endotoxin altering fractions derived from normal human serum. Journal of Immunology, 89, 326-335.
|
[13]
|
Al-Shami, A.K., Itani, L.Y., Skaff, N.N., Haddad, E.K., Abdelnoor, A.M. (1995) Effects of acetyl salicylic acid, tobramycin and vancomycin on some biological activities of endotoxin. EOS Rivista di Immunologia ed Immunofarmacologia, 15, 71-75.
|
[14]
|
David, S.A., Silverstein, R., Amura, C.R., Kielian, T. and Morrison, D.C. (1999) Lipopolyamines: Novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrobial Agents & Chemotherapy, 43(4), 912-919.
|
[15]
|
Moore, R.A., Bates, N.C. and Hancock, R.E. (1986) Interaction of polycationic antibiotics with pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrobial Agents & Chemotherapy, 29(3), 496-500.
|
[16]
|
Jerala, R. and Porro, M. (2004) Endotoxin neutralizing peptides. Current Topics in Medicinal Chemistry, 4(11), 1173-1184.
|
[17]
|
Zorko, M. and Jerala, R. (2008) Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. Journal of Antimicrobial Chemotherapy, 62(4), 730-737.
|
[18]
|
Buttke, T.M. and Ingram, L.O. (1975) Comparison of lipopolysaccharides from agmenellum quadruplicatum to escherichia coli and salmonella typhimurium by using thin-layer chromatography. Journal of Bacteriology, 124(3), 1566-1573.
|
[19]
|
Terao, H., Asano, K., Kanai, K., Kyo, Y., Watanabe, S., Hisamitsu, T., et al. (2003) Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators of Inflamma- tion, 12(4), 195-202.
|
[20]
|
Moreira, A.L., Wang, J., Sarno, E.N. and Kaplan, G. (1997) Thalidomide protects mice against LPS-induced shock. Brazilian Journal of Medical & Biological Research, 30(10), 1199-1207.
|
[21]
|
Kusser, W.C. and Ishiguro, E.E. (1988) Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by escherichia coli. Antimicrobial Agents & Chemotherapy, 32(8), 1247-1250.
|
[22]
|
Sugiyama, K., Shirai, R., Mukae, H., Ishimoto, H., Nagata, T., Sakamoto, N., et al. (2007) Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clinical & Experimental Immunology, 147(3), 540-546.
|
[23]
|
Kaushik V., Beduya D., Kalampokis I., Kohlhoff, S., O Joks R., G Durkin H. and Nowakowski M. (2007) Tetracyclines tigecycline and doxycycline inhibit LPS-induced nitric oxide production by RAW 264.7 murine macro- phages. Journal of Immunology, 178, (101)1-7.
|
[24]
|
Cazalis, J., Bodet, C., Gagnon, G. and Grenier, D. (2008) Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. Journal of Periodontology, 79(9), 1762-1768.
|
[25]
|
Yang, L.P., Zhu, X.A. and Tso, M.O. (2007) Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Molecular Vision, 13, 1083- 1093.
|
[26]
|
Henry, C.J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M.T., et al. (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. Journal of Neuroinflammation, 5, (15)1-14.
|
[27]
|
Eswarappa, S.M., Basu, N., Joy, O. and Chakravortty, D. (2008) Folimycin (concanamycin A) inhibits LPS-induced nitric oxide production and reduces surface localization of TLR4 in murine macrophages. Innate Immunity, 14(1), 13-24.
|
[28]
|
He, H., Genovese, K.J., Nisbet, D.J. and Kogut, M.H. (2006) Involvement of phosphatidylinositol-phospholipase C in immune response to salmonella lipopolysacharide in chicken macrophage cells (HD11). International Immunopharmacology, 6(12), 1780-1787.
|
[29]
|
Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., et al. (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature, 420, 324-329.
|
[30]
|
Bagchi, A., Herrup, E.A., Warren, H.S., Trigilio, J., Shin, H.S., Valentine, C., et al. (2007) MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. Journal of Immunology, 178, 1164-1171.
|
[31]
|
Rabel, F. (2009) Reviving Thin Layer Chromatography. Chromatography Techniques.
http://www.laboratoryequipment.com/article-reviving-thin-layer-chromatography.aspx
|
[32]
|
Timmins, G.S. and Deretic, V. (2006) Mechanisms of action of isoniazid. Molecular Microbiology, 62(5), 1220-1227.
|
[33]
|
Rehan, V.K., Dargan-Batra, S.K., Wang, Y., Cerny, L., Sakurai, R., Santos, J., et al. (2007) A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung. American Journal of Physiology. Lung Cellular and Molecular Physiology, 293(1), 182-190.
|
[34]
|
Behling, U.H. and Nowotny, A. (1977) Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time. Journal of Immunology, 118, 1905-1907.
|
[35]
|
Haas, G.P., Johnson, A.G. and Nowotny, A. (1978) Suppression of the immune response in C3H/HeJ mice by protein-free lipopolysaccharides. Journal of Experimental Medicine, 148(4), 1081-1086.
|